首页|基于5-LOX/LTB4信号通路探讨黄芩苷/栀子苷对PM2.5暴露致血管内皮功能障碍的干预作用及其机制

基于5-LOX/LTB4信号通路探讨黄芩苷/栀子苷对PM2.5暴露致血管内皮功能障碍的干预作用及其机制

扫码查看
目的 基于5-LOX/LTB4信号通路探究黄芩苷/栀子苷(BC/GD)对PM2.5 诱导的血管内皮功能障碍的改善作用及其机制.方法 利用离体肌张力描记技术测定BC/GD对不同状态下血管环张力的影响.将32只大鼠随机分为对照组、PM2.5 组、30 mg·kg-1 BC/GD组和60 mg·kg-1 BC/GD组,利用气管滴注法构建PM2.5 暴露模型,持续2个月,造模1个月后灌胃给予对应药物,持续1个月,末次给药后,HE染色观察肠系膜动脉血管内皮状态;化学发光法检测肠系膜动脉活性氧(ROS)水平;硝酸还原酶法检测一氧化氮(NO)水平;ELISA 法检测血清炎症因子肿瘤坏死因子α(TNF-α)、白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、转化生长因子β1(TGF-β1)、白三烯B4(LTB4)水平;Western blot法检测5-脂氧酶(5-LOX)、内皮细胞一氧化氮合酶(eNOS)、诱导型一氧化氮合酶(iNOS)蛋白表达.结果 BC/GD对基础状态的肠系膜动脉血管环张力无明显影响,但能明显舒张由5-HT预收缩的血管环;一氧化氮合酶抑制剂L-NAME、环氧合酶抑制剂INDO或L-NAME+INDO均能明显抑制BC/GD的血管舒张作用,但L-NAME的抑制作用更明显;50、100 mg·mL-1 PM2.5 能降低血管环对乙酰胆碱(ACh)的舒张血管效应,而BC/GD能明显改善PM2.5 诱导的舒张效应减弱.与对照组相比,PM2.5 组大鼠肠系膜动脉内皮完整性严重受损、内皮皱缩,大鼠血清中TNF-α、IL-1β、IL-6、LTB4水平显著升高、TGF-β1水平显著降低,肠系膜动脉组织中5-LOX、iNOS蛋白表达明显增加,eNOS蛋白表达降低,ROS水平升高,NO水平降低.与PM2.5 组相比,BC/GD能改善内皮损伤程度和完整性,可显著降低血清中TNF-α、IL-1β、IL-6、LTB4水平,升高TGF-β1水平;明显降低肠系膜动脉5-LOX、iNOS表达,升高eNOS蛋白表达;降低ROS水平,升高NO水平.结论 BC/GD可通过抑制5-LOX/LTB4信号通路表达,从而降低ROS水平,抑制炎性损伤,上调eNOS表达,下调iNOS表达,升高血管中NO水平,改善PM2.5 诱导的血管内皮功能障碍.
Intervention of baicalin/geniposide on vascular endothelial dysfunction caused by PM2.5 exposure and its mechanism based on 5-LOX signaling pathway
Objective To determine the ameliorative effect of baicalin/geniposide(BC/GD)on PM2.5-induced vascular endothelial dysfunction and its mechanism based on 5-LOX/LTB4 signaling pathway.Methods The effect of BC/GD on vascular ring tone in different states was determined with an ex vivo muscle tone tracing technique.Thirty-two rats were randomly divided into a control group,a PM2.5 group,a 30 mg·kg-1 BC/GD group and a 60 mg·kg-1 BC/GD group.The exposure model of PM2.5 was established by tracheal instillation for 2 months,and corresponding drugs were given by gavage for 1 month after the model establishment.After the last administration,HE staining was used to observe the endothelial status of mesenteric artery vasculature.Chemiluminescence detected the level of ROS in the mesenteric arteries;nitrate reductase detected the level of NO;serum levels of inflammatory factors TNF-α,IL-1β,IL-6,TGF-β1,and LTB4 were detected by ELISA;and Western blot detected the levels of 5-LOX,eNOS,and iNOS protein expression.Results BC/GD had no significant effect on the mesenteric artery vascular ring tone in the base state,but it significantly diastoled the vascular ring preconstricted by 5-HT.The nitric oxide synthase inhibitor L-NAME,the cyclooxygenase inhibitor INDO,or L-NAME+INDO all significantly inhibited the vasodilatory effect of BC/GD,and the inhibitory effect of L-NAME was more obvious;PM2.5 at 50 mg·mL-1 and 100 mg·mL-1 reduced the vasodilatory effect of vascular ring on acetylcholine,whereas BC/GD significantly ameliorated the PM2.5-induced attenuation of the diastolic effect.The endothelial integrity of the mesenteric arteries was severely impaired and the endothelium was wrinkled in the PM2.5 group.Compared with those of the control group,the serum levels of TNF-α,IL-1β,IL-6,and LTB4 were higher and the level of TGF-β1 much lower in the PM2.5 group,and the protein expression of 5-LOX and iNOS was significantly increased and the expression of eNOS was decreased in the tissue of mesenteric arteries.The ROS level was elevated and the NO level decreased.Compared with the PM2.5 group,BC/GD improved the degree and integrity of endothelial damage to various degrees,significantly reduced the serum levels of TNF-α,IL-1β,IL-6,and LTB4,and increased the level of TGF-β1.Expression of 5-LOX and iNOS was significantly reduced,and eNOS protein expression elevated in the mesenteric arteries;ROS levels reduced,and NO levels elevated.Conclusion BC/GD can inhibit inflammatory injury by inhibiting the expression of the 5-LOX/LTB4 signaling pathway,down-regulating ROS levels,up-regulating eNOS expression,down-regulating iNOS expression,and increasing the level of NO in the vasculature,and improve the degree and integrity of PM2.5-induced vascular endothelial dysfunction.

PM2.5baicalingeniposideendothelial dysfunction5-LOX/LTB4 signaling pathway

孙欠欠、张行行、赵麓、赵安东、史永恒、王川、刘继平、王斌

展开 >

陕西中医药大学药学院,陕西 咸阳 712046

陕西省中医药管理局中药药效机制与物质基础重点研究室,陕西 咸阳 712046

中医药脑健康产业陕西省高校工程研究中心,陕西 咸阳 712046

PM2.5 黄芩苷 栀子苷 内皮功能障碍 5-LOX/LTB4信号通路

中医药"双链融合"中青年科研创新团队国家自然科学基金项目陕西省中医药科研项目咸阳市重点研发科技项目

2022-SLRH-YQ-006814733852021-ZZ-JC023JBGS-001

2024

中南药学
湖南省药学会

中南药学

CSTPCD
影响因子:0.736
ISSN:1672-2981
年,卷(期):2024.22(2)
  • 34